Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin T Jordan

Showing results (21-30 of 92) with videos related to

Pageof 10
Sort By:
Acta Neuropathologica|April 12, 2024
Histologic correlates of "Choroidal abnormalities" in Neurofibromatosis type 1 (NF1)Anat O Stemmer-Rachamimov, Liana Kozanno, Scott R Plotkin, et al.
BMC Health Services Research|August 31, 2018
Increasing access to specialty care for rare diseases: a case study using a foundation sponsored clinic network for patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosisVanessa L Merker, Annie Dai, Heather B Radtke, et al.
Patient Education and Counseling|October 14, 2020
Effective provider-patient communication of a rare disease diagnosis: A qualitative study of people diagnosed with schwannomatosisVanessa L Merker, Scott R Plotkin, Martin P Charns, et al.
Journal of Neuro-Oncology|May 4, 2019
First report of quality of life in adults with neurofibromatosis 2 who are deafened or have significant hearing loss: results of a live-video randomized control trialChristopher J Funes, Ryan A Mace, Erik A Macklin, et al.
The Journal of Biological Chemistry|December 4, 2020
mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibitionRoberta L Beauchamp, Serkan Erdin, Luke Witt, et al.
Orphanet Journal of Rare Diseases|February 11, 2022
Awareness and agreement with neurofibromatosis care guidelines among U.S. neurofibromatosis specialistsVanessa L Merker, Pamela Knight, Heather B Radtke, et al.
Neurology|February 9, 2024
Prescription Drug Prices: An AAN Position StatementJonathan D Santoro, Jason J Sico, James F Burke, et al.
American Journal of Medical Genetics. Part A|May 31, 2022
Genetic testing to gain diagnostic clarity in neurofibromatosis type 2 and schwannomatosisRebecca Burns, Kristin Niendorf, Kathleen Steinberg, et al.
Neurology|February 22, 2023
Teaching NeuroImage: Subacute Quadriparesis From Intramedullary Spinal Cord Infiltrating Glioma With <i>TERT</i> Promoter MutationSimon Gritsch, Yasmin Aghajan, Liana Kozanno, et al.
American Journal of Medical Genetics. Part A|February 18, 2017
First report of factors associated with satisfaction in patients with neurofibromatosisEric Riklin, Mojtaba Talaei-Khoei, Vanessa L Merker, et al.
Pageof 10

Showing results (21-30 of 92) with videos related to

Sort By:
Pageof 10
Acta Neuropathologica|April 12, 2024
Histologic correlates of "Choroidal abnormalities" in Neurofibromatosis type 1 (NF1)Anat O Stemmer-Rachamimov, Liana Kozanno, Scott R Plotkin, et al.
BMC Health Services Research|August 31, 2018
Increasing access to specialty care for rare diseases: a case study using a foundation sponsored clinic network for patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosisVanessa L Merker, Annie Dai, Heather B Radtke, et al.
Patient Education and Counseling|October 14, 2020
Effective provider-patient communication of a rare disease diagnosis: A qualitative study of people diagnosed with schwannomatosisVanessa L Merker, Scott R Plotkin, Martin P Charns, et al.
Journal of Neuro-Oncology|May 4, 2019
First report of quality of life in adults with neurofibromatosis 2 who are deafened or have significant hearing loss: results of a live-video randomized control trialChristopher J Funes, Ryan A Mace, Erik A Macklin, et al.
The Journal of Biological Chemistry|December 4, 2020
mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibitionRoberta L Beauchamp, Serkan Erdin, Luke Witt, et al.
Orphanet Journal of Rare Diseases|February 11, 2022
Awareness and agreement with neurofibromatosis care guidelines among U.S. neurofibromatosis specialistsVanessa L Merker, Pamela Knight, Heather B Radtke, et al.
Neurology|February 9, 2024
Prescription Drug Prices: An AAN Position StatementJonathan D Santoro, Jason J Sico, James F Burke, et al.
American Journal of Medical Genetics. Part A|May 31, 2022
Genetic testing to gain diagnostic clarity in neurofibromatosis type 2 and schwannomatosisRebecca Burns, Kristin Niendorf, Kathleen Steinberg, et al.
Neurology|February 22, 2023
Teaching NeuroImage: Subacute Quadriparesis From Intramedullary Spinal Cord Infiltrating Glioma With <i>TERT</i> Promoter MutationSimon Gritsch, Yasmin Aghajan, Liana Kozanno, et al.
American Journal of Medical Genetics. Part A|February 18, 2017
First report of factors associated with satisfaction in patients with neurofibromatosisEric Riklin, Mojtaba Talaei-Khoei, Vanessa L Merker, et al.
Pageof 10